Venetoclax Exposure-Efficacy and Exposure-Safety Relationships in Subjects with Treatment-Naïve Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy

MLA

Jiuhong Zha, et al. “Venetoclax Exposure-Efficacy and Exposure-Safety Relationships in Subjects with Treatment-Naïve Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy.” Blood, vol. 136, Nov. 2020, p. 52. EBSCOhost, https://doi.org/10.1182/blood-2020-136425.

APA

Jiuhong Zha, Ahmed Salem, Doerthe Eckert, Deanna Brackman, Sven Mensing, B. Douglas Smith, John Hayslip, Rajeev M. Menon, Jalaja Potluri, Sathej Gopalakrishnan, Andrew H. Wei, & Dale Miles. (2020). Venetoclax Exposure-Efficacy and Exposure-Safety Relationships in Subjects with Treatment-Naïve Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy. Blood, 136, 52. https://doi.org/10.1182/blood-2020-136425

Chicago

Jiuhong Zha, Ahmed Salem, Doerthe Eckert, Deanna Brackman, Sven Mensing, B. Douglas Smith, John Hayslip, et al. 2020. “Venetoclax Exposure-Efficacy and Exposure-Safety Relationships in Subjects with Treatment-Naïve Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy.” Blood 136 (November): 52. doi:10.1182/blood-2020-136425.